Home > Work packages > Low-tech risk reduction (WP4) Low-tech risk reduction (WP4) Evaluating the low-tech risk reduction measures and their potential to reduce emissions of pharmaceuticals to the environment. 1. Take-back and disposal of unused medicinesObjectives Evaluation of current national practices for take-back and disposal of unused medicines Spreading good practices for take-back and disposal of unused medicines to reduce their disposal via solid waste stream or sewage systems Activities Evaluation and development of current national practices in all partner countries 2. Increased awareness of environmental impacts of APIsObjective Recommendations on efficient dissemination of environmental information on pharmaceutical products throughout the Baltic Sea Region Activities Swedish experiences will be evaluated and gaps related to utilization of information will be identified 3. Enhanced environmental permitting of pharmaceutical plantsObjectives Spread good practices for environmental permitting of pharmaceutical plants Enhance permitting of pharmaceutical plants within current legislation framework Activities Evaluation of current national practices in the Baltic Sea Region for environmental permitting of pharmaceutical plants and for industrial wastewater contracts between municipal wastewater treatment plants and pharmaceutical plants 4. Output A report on low-tech risk reduction measures to reduce emissions of pharmaceuticals Identification of priority measures and recommendations to be used by policy makers and environmental authorities and municipalities WP4 leader: Jukka Mehtonen, Finnish Environment Institute (SYKE)Partners Finnish Environment Institute (SYKE) County Administrative Board (CAB) Estonian Environmental Research Centre (EERC) Berlin Centre of Competence for Water (KWB) Kalundborg Utility Finnish Medicines Agency (Fimea) Institute of Environmental Protection – National Research Institute (IOS) Latvian Environment, Geology and Meteorology Centre (LEGMC) Estonian Waterworks Association (EVEL) Published 2017-12-15 at 13:34, updated 2018-04-26 at 16:29 Share: More information on pharmaceuticals